Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   ACTAVIS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
ACTAVIS
Dec-18
PROCTER & GAMBLE HEALTH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs5,36616,159-   
Low Rs3,88310,840-   
Sales per share (Unadj.) Rs740.73,963.8-  
Earnings per share (Unadj.) Rs138.2-1,276.8-  
Cash flow per share (Unadj.) Rs155.2417.7-  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.616,349.0-  
Shares outstanding (eoy) m16.60332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.23.4 183.3%   
Avg P/E ratio x33.5-10.6 -316.4%  
P/CF ratio (eoy) x29.832.3 92.2%  
Price / Book Value ratio x10.30.8 1,251.1%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,7614,489,898 1.7%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,0620-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m12,2961,318,372 0.9%  
Other income Rs m18425,212 0.7%   
Total revenues Rs m12,4801,343,584 0.9%   
Gross profit Rs m3,24734,548 9.4%  
Depreciation Rs m281563,576 0.0%   
Interest Rs m876,078 0.0%   
Profit before tax Rs m3,142-579,893 -0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m847-7,349 -11.5%   
Profit after tax Rs m2,295-424,648 -0.5%  
Gross profit margin %26.42.6 1,007.6%  
Effective tax rate %27.01.3 2,127.9%   
Net profit margin %18.7-32.2 -57.9%  
BALANCE SHEET DATA
Current assets Rs m11,713540,727 2.2%   
Current liabilities Rs m6,791478,345 1.4%   
Net working cap to sales %40.04.7 846.0%  
Current ratio x1.71.1 152.6%  
Inventory Days Days26320 1,341.8%  
Debtors Days Days34366 518.0%  
Net fixed assets Rs m10,617149,232 7.1%   
Share capital Rs m1660-   
"Free" reserves Rs m7,2650-   
Net worth Rs m7,4315,437,670 0.1%   
Long term debt Rs m01,914,801 0.0%   
Total assets Rs m22,3308,500,316 0.3%  
Interest coverage x409.1-6.6 -6,176.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.2 355.0%   
Return on assets %10.3-4.1 -251.4%  
Return on equity %30.9-7.8 -395.4%  
Return on capital %42.4-4.8 -875.7%  
Exports to sales %00-   
Imports to sales %13.10-   
Net fx Rs m-1400-   
CASH FLOW
From Operations Rs m2,360471,005 0.5%  
From Investments Rs m-215258,756 -0.1%  
From Financial Activity Rs m-985-808,385 0.1%  
Net Cashflow Rs m1,160-78,232 -1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PROCTER & GAMBLE HEALTH With: GLENMARK PHARMA  BERYL DRUGS  ZENITH HEALTH  DISHMAN PHARMA  KILITCH DRUGS  



Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.